Immunomodulatory drug maintenance therapy vs placebo/observation
Treatment discontinuation · people with chronic lymphocytic leukaemia
It is very uncertain whether immunomodulatory drug maintenance therapy changes treatment discontinuation compared with placebo/observation (very low certainty).
1 finding from 1 review
- Risk ratio 0.71 [0.47, 1.05]2 studies · 400 participantsVery low